Unlocking the Power of the Genome At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of …

Sectors: Biotechnology

[Automatic translation follows] The priorities of the Ministry of National Education, Higher Education and Research are: - to improve student success and promote equal opportunities; - to coordinate the training offer of French higher education; - to set priority areas for the progress of knowledge and technologies; - as well as the public research and innovation strategy. In this context, the so-called "ESR" law of July 22, 2013 also advocates transformation and openness to all forms of teaching and research, to the socio-economic environment, and to the international. Among the key measures put in place: - The definition of a …

[Automatic translation follows] Dalkia: together, let's take on the climate challenge! For 85 years, Dalkia, a subsidiary of the EDF group and a leader in energy services, has been investing in and developing renewable and recovery energies and supporting its customers over the long term to help them save energy and reduce their CO2 emissions. More than 20,000 employees throughout France and internationally ensure the maintenance and operation of installations on industrial sites, tertiary buildings, communities, healthcare facilities and housing, with innovative and efficient solutions, to accelerate the decarbonisation of sites and regions. Find our solutions on our eco-responsible website …

Sectors: Real Estate

Pioneering Diagnostics Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. …

Sectors: Biotechnology

New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale …

Sectors: Pharmaceutical

[Automatic translation follows] Startup studio with impact. For our health, our planet and our economy WAOUP is a Startup Studio with impact. We create, accelerate and finance tech startups, with labs, entrepreneurs, companies and investors. And we create for and with companies, the future innovative and responsible business models. We are a mission-driven company that is committed to: - For our planet, by supporting and accelerating ecological transitions ‍- For our health, by rethinking our healthcare systems and its access everywhere and for everyone ‍- For our economy, by acting in the service of more responsible development models - And …

enabling humans for tomorrow Building a Better Future, Together At the heart of southern France, nestled in lush greenery between Aix-en-Provence and Marseille, thecamp is much more than a place—it’s a movement. Our mission? To shape a more human, responsible, and sustainable world by bringing together companies, local governments, territories, and individuals in one unique space. At thecamp, we don’t just talk about the future; we build it. From tackling today’s most pressing challenges to co-creating the socio-economic models of tomorrow, we provide an ecosystem where transformative ideas thrive. Whether it’s forging unlikely collaborations or testing bold solutions in real-world …

Sectors: Startup accelerator & VC

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

Agir ici. Changer demain. ONLYLYON is both the brand and the international marketing programme created in 2007 by the 13 institutional partners across the Lyon area who share the same objective: to strengthen the reputation and competitiveness of Lyon in a context of growing competition between world cities in attracting talent, companies, projects and tourists. This initiative brings together 24 public and private partners. The ONLYLYON initiative is wide-ranging, both in terms of its fields of application (sectors, markets) and the kinds of activities it carries out (communications, press relations, ambassador networks, digital strategy, etc.), its mission being to promote …

Sectors: National and local authorities

[Automatic translation follows] An administration in motion is a whole city that moves #villedelyon! Capital of the Rhône-Alpes Region, Lyon is one of the most attractive cities in Europe for its quality of life and its exceptional economic dynamism. At the heart of the Lyon Metropolis, the City of Lyon (500,000 inhabitants) has a total budget of 780 million euros and a workforce of 7,300 permanent agents allowing it to offer a local public service to the population with a constant concern for quality. Would you like to discover our professions, find out about recruitment procedures or apply for our …

Sectors: French metropolis National and local authorities

[Automatic translation follows] #auvergnerhonealpes Auvergne-Rhône-Alpes is a large region with many assets: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th most populated region in Europe - Covering nearly 70,000 km2, or 13% of the metropolitan territory, its surface area is equivalent to that of Ireland. - In France, it is the leading industrial and gastronomic region, it ranks first for agricultural production under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe …

Sectors: National and local authorities

[Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its …

Sectors: Startup accelerator & VC

The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients.

Sectors: Biotechnology French Cluster Public business cluster

The World Bank is a vital source of financial and technical assistance to developing countries around the world. Our vision is to create a world without poverty on a livable planet. We are not a bank in the common sense; we are made up of two unique development institutions owned by 189 member countries: the International Bank for Reconstruction and Development (IBRD) and the International Development Association (IDA). Each institution plays a different but collaborative role in advancing the vision of inclusive and sustainable globalization. The IBRD aims to reduce poverty in middle-income and creditworthy poorer countries, while IDA focuses …

Sectors: International development

[Automatic translation follows] Official account of the Ministry of Health and Access to Care. The Ministry of Health and Access to Care prepares and implements the Government's policy in the areas of public health, prevention and access to care. health, solidarity, public administration, poverty, care, and solidarity

At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​ All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. ​ Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals

Sectors: Pharmaceutical

The official #EUGreenCapital and #EUGreenLeaf Awards. Our aim is to improve Europe's urban environment. The European Green Capital and European Green Leaf awards are a European Commission initiative to recognise a city's commitment to a better urban environment. Cities with populations over 100,000 inhabitants are eligible to apply for the European Green Capital Award while the European Green Leaf is open to cities of between 20,000 and 100,000 inhabitants. Winners demonstrate well-established records of high environmental standards and a commitment to setting ambitious goals for future environmental progress, underpinned by the practical application of sustainable development. The schemes have a …

Sectors: European Union

[Automatic translation follows] Responsible third places to act in favor of the ESS, for sustainable real estate and for solidarity finance. As a pioneering player in impactful third places, ETIC works in metropolitan France, by designing, managing, financing, operating and running workspaces in eco-responsible buildings, dedicated to actors of societal change and financed by solidarity investors. ETIC operates 8 workspaces (Paris, Lyon, Toulouse, Castres and Grenoble) and others are in the pipeline (Paris, Lille, Avignon, etc.). Our third places now bring together more than 170 committed structures, spread throughout France, which share work and living spaces on a daily basis, …

Sectors: Real Estate

Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our …

Sectors: Pharmaceutical

[Automatic translation follows] France's leading producer of 100% renewable electricity CNR is the leading French producer of 100% renewable electricity (water, wind, sun) and the multi-purpose concessionaire of the Rhône from the Swiss border to the Mediterranean Sea: hydroelectricity production, deployment of navigation and port areas, irrigation and other agricultural uses. A public limited company of general interest, CNR stands out for its industrial model based on regional development and its unique system for sharing locally created value with its stakeholders. At the forefront of its businesses, which it is constantly developing through an active innovation approach, CNR offers its …

Sectors: Energy

Pour une #science actrice d’un futur durable, le #partenariat scientifique équitable avec les pays en #développement IRD is a French public research institute working for the development of Southern countries, reporting to the Ministries responsible for research and overseas development. IRD is managing for more than sixty years research, consultancy and capacity building activities in Africa, the Mediterranean basin, Asia, Latin America and French overseas territories. IRD researchers address major development challenges regarding environment, sustainable development of living resources, social studies and health. https://youtu.be/MtuGHK6ogR0 🎬 http://lemag.ird.fr/frlUOL Research

[Automatic translation follows] The Agence Française de Développement (AFD) group finances and accelerates transitions towards a more sustainable world As a public institution, the Agence Française de Développement (AFD) has been working for seventy years to combat poverty and promote development in the countries of the South and in the Overseas Territories. It implements the policy defined by the French Government. Present on four continents where it has a network of 70 agencies and representative offices worldwide, including 9 in the Overseas Territories and 1 in Brussels, the AFD finances and supports projects that improve the living conditions of populations, …

Sectors: International development

France Diplomatie @francediplo We’re the French Ministry for Europe and Foreign Affairs. We’ll tell you about our foreign policy, our work on trade and FDI, and more generally about how France is meeting global challenges. diplomatie, culture, politique, humanitaire, ministère, affaires étrangères, francophonie, développement, and Français de l'étranger

The leading media brand empowering startup Europe | Backed by the Financial Times. Sifted is the critical friend of the European startup ecosystem – providing startup founders, senior management teams, investors and service providers with the curated insights, in-depth analysis and networking opportunities they need to grow their business. Whatever your role is within the ecosystem, however you like to stay up to speed, we've got something for you: 🗞️ Sifted Daily: Our daily newsletter is the essential morning read for founders, investors and corporates who want a quick digest of the news that matters 🔎 Sifted Pro: Our premium …

Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Sectors: Biotechnology Pharmaceutical

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines

Sectors: Pharmaceutical

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, …

Sectors: Biotechnology Pharmaceutical

Aiming to promote nuclear disarmament and non-proliferation and the strengthening of the disarmament regimes. The Office for Disarmament Affairs supports multilateral efforts aimed at achieving the ultimate goal of general and complete disarmament under strict and effective international control.

Sectors: International development

We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.

Sectors: Pharmaceutical